US Pentagon Mandates Testosterone Screening For Troops Over 30

The United States Department of Defense has announced a new policy requiring all military personnel over the age of 30 to undergo testosterone screening. Defense Secretary Hegseth confirmed the directive, which aims to identify and treat hormone deficiencies within the armed forces. This initiative marks a significant shift in medical standards for active-duty members. The screening will become a routine part of health evaluations for hundreds of thousands of troops across all branches.

The decision follows growing concerns within the Pentagon regarding physical performance and mental health among older service members. Low testosterone levels are often linked to reduced muscle mass, fatigue, and decreased focus, which can impair operational effectiveness. Defense officials believe that addressing these biological factors will enhance long-term combat readiness. The program also seeks to standardize hormone treatments across the military healthcare system. This policy reflects a broader effort to modernize soldier wellness and maintenance protocols.

While the policy is specific to the United States, it may set a new international benchmark for military medical screening. For India, these developments are closely watched by defense planners who often evaluate global best practices for troop welfare. The implementation will require a massive logistical effort to ensure testing capacity at all US bases worldwide. Critics have raised questions about privacy and the long-term cost of mandatory hormone replacement therapies. However, the Pentagon maintains that the benefits to personnel health outweigh these operational challenges.